Sarepta Therapeutics, Inc. (SRPT)
NASDAQ: SRPT · Real-Time Price · USD
23.03
+1.24 (5.69%)
At close: May 6, 2026, 4:00 PM EDT
21.84
-1.19 (-5.17%)
After-hours: May 6, 2026, 7:55 PM EDT

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Total PMO Products Revenue
957.58M965.57M967.17M
Total PMO Products Revenue Growth
-0.83%-0.17%2.40%
ELEVIDYS Revenue
625.71M898.73M820.79M
ELEVIDYS Revenue Growth
-30.38%9.50%309.67%
Total Products Revenue
1.58B1.86B1.79B
Total Products Revenue Growth
-15.07%4.27%56.17%
Collaboration and Other Revenue
600.90M333.94M114.02M
Collaboration and Other Revenue Growth
79.94%192.88%15.80%
Revenue (Other)
-1.58B-1.86B-1.79B
Revenue (Total)
2.18B2.20B1.90B
Revenue (Total) Growth
-0.64%15.58%52.97%
Updated May 6, 2026. Data Source: Fiscal.ai.